Role of Autologous Fibrin Glue (AFG) to Reduce Drainage Volume After Modified Radical Mastectomy for Breast Cancer
Background: Seroma is arguably the most significant complication that can happen after mastectomy. Although seroma is not a life-threatening complication, this condition can lead to severe morbidities. This situation can cause prolonged hospital stays and delayed adjuvant therapy. In this regard, autologous fibrin glue is a hemostatic agent that can accelerate fibrin formation, stop vascular oozing, and decrease dead space. Therefore, this research was performed to evaluate autologous fibrin glue function in lowering seroma volume after mastectomy and shortening the length of hospital stay.
Methods: This randomized control trial research was designed to compare the effect of autologous fibrin glue to a control group that did not receive autologous fibrin glue. Seroma volume was calculated every 24 hours. The drains were then removed after the production of seroma less than 30 mL/24 hours.
Results: We recruited 20 patients for each of the two groups who met the inclusion criteria. Age, histopathology type, breast cancer stage, number of lymph nodes, and tumor size did not significantly differ. However, patients in the fibrin glue group had significantly lower cumulative drain production. The median seroma volume in the treatment group was 9.30 mL, while the median in the control group was 20.90 mL (p < 0.05).
Conclusions: Autologous fibrin glue significantly decreased seroma formation and length of hospital stay.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer
statistics 2018: GLOBOCAN estimates of incidence
and mortality worldwide for 36 cancers in 185
countries. CA Cancer J Clin. 2018;68(6):394–424.
Azhar Y, Agustina H, Abdurahman M, Achmad D.
Breast cancer in West Java: Where do we stand
and go?. Indones J Cancer. 2020;14(3):91–6.
Akinci M, Cetin B, Aslan S, Kulacoglu H. Factors
affecting seroma formation after mastectomy with full
axillary dissection. Acta Chir Belg. 2009;109:481–483.
Junior NO. Hubungan antara seroma dengan body
mass index dan kadar lekosit cairan seroma. Surgical
Oncology Consultant [dissertation]. Bandung: Padjajaran University; 2010.
Pogson CJ, Adwani A, Ebbs SR. Seroma following breast cancer surgery. Eur J Surg Oncol. 2003;29:711–7.
Udén P, Aspegren K, Balldin G, et al. Fibrin adhesive
in radical mastectomy. Eur J Surg. 1993;159(5):263–5.
Langer S, Guenther JM, DiFronzo LA. Does fibrin
sealant reduce drain output and allow earlier removal
of drainage catheters in women undergoing operation
for breast cancer? Am Surg. 2003;69(1):77–81.
Carless PA, Henry DA. Systematic review and metaanalysis of the use of fibrin sealant to prevent
seroma formation after breast cancer surgery. Br J
Düregger K, Frenzel S, Eblenkamp M. Autologous
fibrin glue: automated production and adhesive
quality. Curr Dir Biomed Eng. 2017;3:397–400.
Chang YT, Shih SL, Loh EW, Tam KW. Effects of
fibrin sealant on seroma reduction for patients with
breast cancer undergoing axillary dissection: metaanalysis of randomized controlled trials. Ann Surg
R. Tasinato, M. Godina, L. Griggio et al., “Prevenzione
della linforrea ascellare nelle pazienti sottoposte a
linfadenectomia per carcinoma mammario,” Acta
Chirurgica Italica,1993;49, pp. 479–484
Cavichiolo, Benthien J, Buschle M, & Carvalho B.
Comparison of fibrin adhesives prepared by 3
different methods. International Archives of
Otorhinolaryngology, 2013; 17(1), 62–65. https://
Article MetricsAbstract view : 141 times
PDF - 165 times
- There are currently no refbacks.
Copyright (c) 2021 Indonesian Journal of Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.